Interestingly, clinical epidemiological data shows that even if metabolic abnormalities like obesity, dyslipidemia or T2DM are absent, NAFLD may be seen in the subjects with variant PNPLA3 [36, 37]. The gene discussed is PNPLA3; the disease is obesity due to melanocortin 4 receptor deficiency.